
|Articles|May 28, 2008
FDA warns that nipple cream can hurt nursing babies
FDA warns about the dangers in Mommy's Bliss Nipple Cream.
Advertisement
Even though Mommy’s Bliss Nipple Cream states that there is no need for moms to remove the cream before nursing, the Food & Drug Administration has just issued a warning that this is far from the truth. Designed to sooth and heal dry or cracked nipples, the product contains two ingredients that may cause respiratory distress or vomiting and diarrhea in infants. The two ingredients are chlorphenesin, which can depress the central nervous system and cause slow or shallow breathing in infants, and phenoxyethanol, which can lead to vomiting and diarrhea in babies and dermatitis in their mothers. MOM Enterprises Inc., San Rafael, Calif., said it has stopped selling the product.
Advertisement
Related to this article

The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.

The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.

Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.

The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.

In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.

Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.

Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
3
Doxycycline Use Associated with Higher Risk of Pregnancy Loss
4
New Report Finds Pharmacies Key in Long-Term GLP-1 Success
5

